Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

BACKGROUND: Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART). Rifabutin allows more regimens options for concomitant imunodeficiency virus (HIV) treatment compared to rifampicin. OBJECTIVE: Compare the ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmaltz, Carolina Arana Stanis, Demitto, Fernanda de Oliveira, Sant’Anna, Flavia Marinho, Rolla, Valeria Cavalcanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372173/
https://www.ncbi.nlm.nih.gov/pubmed/30758392
http://dx.doi.org/10.1590/0074-02760180420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372173/
https://www.ncbi.nlm.nih.gov/pubmed/30758392
http://dx.doi.org/10.1590/0074-02760180420

Ejemplares similares